MODERN VIEWS ON JUVENILE MYOCLONIC EPILEPSY

Аннотация

Juvenile myoclonic epilepsy (JME) is a common idiopathic epilepsy, accounting for 10% of all epilepsies. It is characterized as a syndrome of generalized genetic epilepsy with a peak development at the age of 12-18 years. The disease was initially thought to have a benign lifelong course due to normal intelligence and positive response to antiepileptic drugs (AEDs). As a result of new research, juvenile myoclonic epilepsy (JME) is no longer considered a homogeneous disease. However, recent studies indicate that cognitive dysfunction and neuropsychological impairment are a major component of the JME phenotype.